Skip to main content

Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity.

Zhao Y, Feng G, Zhang J, Gong R, Cai C, Feng L

Publication: Sci Rep (2017) • Vol 7 • Page 12179PMID: 28939816View on PubMed

Purpose

This paper investigated the effects of frozen storage temperature and duration on coagulation testing in plasma specimens. Differences in results based on analyzer used were also examined.

Conclusion

Prothrombin time (PT), thrombin time (TT), international normalized ratio (INR), activated partial thromboplastin time (APTT), Factor (F)VIII-C, and FIX-C levels were significantly affected by storage at -20 or -80˚C, but fibrinogen levels were generally stable. Storage at -20˚C resulted in clinically relevant changes (>10%) in APTT and FVIII-C after more than 15 days and in PT, INR, and FIX-C after more than 1 month.  Clinically significant effects of storage at -80˚C were limited to FVIII-C and FIX-C when stored for more than 1 month and APTT after more than 6 months. No clinically significant effects of storage on TT or fibrinogen were observed. Importantly, stability times were consistent between analyzers.

Studies (1)

Purpose

This study investigated the effects of frozen storage temperature and duration on coagulation testing in plasma specimens. Differences in results based on analyzer used were also examined. Blood was collected by venipuncture in sodium citrate tubes following a 12 h fast from 144 asymptomatic patients. Plasma was obtained by centrifugation at 3000 x g and specimens were aliquoted. Specimens from 36 patients were processed as one of four groups: 1) frozen and stored at -20˚C and analyzed using the CA7000 system, 2) frozen and stored at -80˚C and analyzed using the CA7000 system, 3) frozen and stored at -20˚C and analyzed using the CS5100 system, or 4) frozen and stored at -80˚C and analyzed using the CS5100 system. One specimen from each patient was analyzed immediately after collection and additional aliquots were tested after 15 days, 1 month, 3 months, 6 months, and 1 year. Specimens were thawed in a 37˚C water bath for 10 min, inverted six times, and analyzed within 30 min of thawing. Clinical significance was defined as a change of more than 10%.

Summary of Findings

Significant increases in PT, TT, INR, APTT, FVIII-C, and FIX-C were observed after 15 days at -20˚C and at -80˚C, depending on analyzer used and after 1 month, regardless of analyzer.  Clinically significant increases (>10%) in PT and INR were only observed after storage at -20˚C for more than 1 month and were not observed at -80˚C for up to 1 year of storage. Clinically significant increases in APTT were observed after storage at -20˚C for more than 15 days or -80˚C for more than 6 months, regardless of analyzer used. Clinically significant decreases of FVIII-C and FIX-C were observed after storage for more than 1 month at -80˚C or after storage at -20˚C for more than 15 days and 1 month, respectively. Although TT increased with storage at either temperature, no clinically significant effects were observed. Fibrinogen levels were relatively stable over the course of 1 year of storage with only small (<1%) changes observed during storage at either temperature. Importantly, stability times were consistent between analyzers.

  • Biospecimens

    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Not specified
  • Platforms

    GlycoproteinHematology/ auto analyzer
    ProteinHematology/ auto analyzer
    MorphologyHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    StorageStorage duration
    0 days
    1 month
    1 year
    15 days
    3 months
    6 months
    StorageStorage temperature
    -20˚C
    -80˚C
    Hematology/ auto analyzer SpecificTechnology platform
    CA7000
    CS5100